CONGENITAL APLASIA

This adverse event was reported 311 times

CONGENITAL APLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CALASPARGASE PEGOL 8 0.0100
1 PEGFILGRASTIM-BMEZ 4 0.0066
2 RYDAPT 11 0.0056
3 DAUNORUBICIN HYDROCHLORIDE 9 0.0055
4 GLOFITAMAB 9 0.0033
5 GEMTUZUMAB OZOGAMICIN 10 0.0027
6 (DAUNORUBICIN AND CYTARABINE) LIPOSOME 6 0.0025
7 ZONISAMIDE 23 0.0021
8 THIOTEPA 19 0.0019
9 BUSULFAN 30 0.0019
See all drugs enriched for association with CONGENITAL APLASIA